NX PRENATAL INC has a total of 19 patent applications. Its first patent ever was published in 2013. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets computer technology, pharmaceuticals and measurement are LIPOMICS TECHNOLOGIES INC, BOSTON HEART DIAGNOSTICS CORP and ATTOQUANT DIAGNOSTICS GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | United States | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | China | 3 | |
#5 | Republic of Korea | 2 | |
#6 | Singapore | 2 |
# | Industry | |
---|---|---|
#1 | Computer technology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Chemical engineering |
# | Name | Total Patents |
---|---|---|
#1 | Brohman Brian D | 18 |
#2 | Doss Robert C | 16 |
#3 | Rosenblatt Kevin Paul | 10 |
#4 | Zhang Zhen | 10 |
#5 | Rosenblatt Kevin P | 7 |
#6 | Mcelrath Thomas F | 6 |
#7 | Ezrin Alan M | 6 |
#8 | Goudy Kevin S | 4 |
#9 | Khalid Malik | 1 |
#10 | Khaja Najmuddin | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020097593A1 | Tandem-paired column chemistry for high-throughput proteomic exosome analysis | |
CN111989090A | Use of stratified spontaneous preterm birth risk of circulating microparticles | |
SG11202007319SA | Methods of early prediction and prevention of preeclampsia utilizing circulating microparticle-associated biomarkers | |
WO2017096405A1 | Use of circulating microparticles to stratify risk of spontaneous preterm birth | |
US2015355188A1 | Treatment of spontaneous preterm birth | |
EP2939022A1 | Biomarkers of preterm birth |